GGrantIndex
Sort

40,608 grants matching prostate cancer

REU Site: Tuskegee University Research Experience for Undergraduates in Nano-Bio Materials Science and Engineering

$377,994
Shaik Zainuddin · Tuskegee University · · FY2017 · MPS

Effectors of protein kinase C-mediated tumor progression

$377,972
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2019 · CA

Understanding optimal delivery systems for cancer care

$377,902
David C Miller · University Of Michigan At Ann Arbor · R01 · FY2015 · CA

Multifunctional immunoPET tracers for pancreatic and prostate cancer

$377,890
Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

Education Program in Cancer Prevention

$377,886
Joel L Weissfeld · University Of Pittsburgh At Pittsburgh · R25 · FY2008 · CA

Opening the Therapeutic Window for PSMA-Targeted Molecular Radiotherapy

$377,875
Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2021 · CA

Development of peptide antagonists of estrogen signaling

$377,850
Duke University · R01 · FY2002 · CA

Role of BMP and FGF signaling during limb development

$377,827
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Molecular Analysis of Prostate Tumor-Initiating Cells

$377,794
Michael M. Shen · Columbia University Health Sciences · P01 · FY2013 · CA

Core - Biomarker Development Laboratory (BDL)

$377,760
James G. Herman · University Of Pittsburgh At Pittsburgh · U2C · FY2024 · CA

Prostate Cancer Screening: Fostering Informed Decisions

$377,740
Georgetown University · R01 · FY2005 · CA

Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer

$377,730
Ming Hui Chen · Duke University · R01 · FY2023 · CA

Understanding optimal delivery systems for cancer care

$377,699
David C Miller · University Of Michigan At Ann Arbor · R01 · FY2017 · CA

Understanding optimal delivery systems for cancer care

$377,699
David C Miller · University Of Michigan At Ann Arbor · R01 · FY2016 · CA

ATLANTA REGIONAL COMMUNITY CLINICAL ONCOLOGY PROGRAM

$377,690
St. Joseph'S Hospital · U10 · FY2000 · CA

Mullerian Inhibiting Substance

$377,678
Patricia K Donahoe · Massachusetts General Hospital · R01 · FY2006 · CA

Phage Display and Prostate Neoplasia Progression

$377,646
Emory University · R33 · FY2003 · CA

Sympathetic modulation of head and neck cancer pain

$377,625
Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE

Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer

$377,625
Haojie Huang · Mayo Clinic Rochester · R01 · FY2021 · CA

Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer

$377,625
Haojie Huang · Mayo Clinic Rochester · R01 · FY2020 · CA

Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer

$377,625
Haojie Huang · Mayo Clinic Rochester · R01 · FY2017 · CA

Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer

$377,625
Haojie Huang · Mayo Clinic Rochester · R01 · FY2018 · CA

Sympathetic modulation of head and neck cancer pain

$377,625
Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE

Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition

$377,601
Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

TRANSGENIC MOUSE MODEL FOR PROSTATE CANCER

$377,567
Vanderbilt University · R01 · FY2001 · CA